Influence of several classes beta-adrenoblockers on hemostasis system in patients with chronic heart failure of postinfarction genesis. Advantages of carvedilol

Influence of carvedilol and metoprolol tartrate on hemostasis system was studied in 60 patients having chronic heart failure of postinfarction genesis in the process of programmed therapy. Thirty patients (main group) received carvedilol, 30 patients (comparison group) received metoprolol. In hospital stage, laboratory thrombophylia was revealed in all chronic heart failure patients. After 4 months of treatment, positive shifts in hemostasis system were obtained in both groups of patients but more marked optimization of hemostasis system was seen in main group.